The VENTOR Clinical Study for Cardiac Arrest
This study is testing a device called Ventor Airway System to see if it can safely and effectively help people breathe during cardiopulmonary resuscitation (CPR) or when they stop breathing. Researchers want to see if the Ventor device can deliver oxygen and help with ventilation (breathing) during the first hour after it's inserted. They are looking for about 25 adults between 18 and 75 years old who have had a non-traumatic cardiac arrest (when the heart suddenly stops beating). You cannot join if you are already on a breathing tube (endotracheal tube), have a "do not attempt resuscitation" order, or if your family objects to your participation. The current status of this study is unclear.
- Study design
- This is an interventional study planning to enroll 25 participants. It is designed to evaluate the Ventor device's safety and effectiveness.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The main measurements for this study will be taken from the time the device is inserted through the first hour.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The VENTOR Clinical Study
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Jignesh Patel, M.D., M.Sc. · PRINCIPAL_INVESTIGATOR · Stony Brook University Hospital
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Ability to provide oxygenation during CPRFrom device insertion through 1 hour.
As measured through the monitoring of intra-arrest PaO2
- Ability to provide ventilation during CPRFrom device insertion through 1 hour
As measured through the monitoring of intra-arrest PaCO2
- Ability to provide oxygenation during CPRFrom device insertion through 1 hour
As measured through the monitoring of intra-arrest cerebral oximetry
- Number of participants with device-related adverse eventsFrom device insertion through 3 months
Number and rate of adverse events